Publication Name	World Journal of Gastroenterology
Manuscript ID	24836
Country	United States

Received	2016-02-11 12:34
Peer-Review Started	2016-02-11 19:13
To Make the First Decision	2016-03-21 09:20
Return for Revision	2016-03-21 13:53
Revised	2016-03-25 23:38
Second Decision	2016-03-30 16:43
Accepted by Journal Editor-in-Chief	2016-03-30 20:08
Accepted by Executive Editor-in-Chief	2016-04-07 16:06
Articles in Press	2016-04-07 16:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-08 19:44
Publish the Manuscript Online	2016-05-19 14:49

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Manuscript Source	Invited Manuscript
All Author List	Jordan E Axelrad, Simon Lichtiger and Vijay Yajnik
Funding Agency and Grant Number
Corresponding Author	Vijay Yajnik, MD, PhD, Department of Medicine, Division of Gastroenterology, The Massachusetts General Hospital, Crohn’s and Colitis Center, 165 Cambridge Street 9th Floor, Boston, MA 02445, United States. vyajnik@mgh.harvard.edu
Key Words	Inflammatory bowel disease; Cancer; Anti-tumor necrosis factor; Immunosuppression; Chemotherapy; Radiation
Core Tip	Patients with inflammatory bowel disease (IBD) and cancer represent a challenging population. Gastroenterologists and oncologists caring for patients with IBD and cancer are increasingly confronted with questions regarding the management of IBD after a diagnosis of cancer, and conversely, the management of cancer in patients with IBD. This review seeks to explore the characteristics, risks, and pathogenesis of cancer in patients with IBD, and to evaluate the data on patients with IBD and cancer, including the interaction between IBD and cancer treatment.
Publish Date	2016-05-19 14:49
Citation	Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol 2016; 22(20): 4794-4801
URL	http://www.wjgnet.com/1007-9327/full/v22/i20/4794.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i20.4794

Full Article (PDF)	WJG-22-4794.pdf
Full Article (Word)	WJG-22-4794.doc
Manuscript File	24836-Review.docx
Answering Reviewers	24836-Answering reviewers.pdf
Audio Core Tip	24836-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	24836-Conflict-of-interest statement.pdf
Copyright License Agreement	24836-Copyright assignment.pdf
Peer-review Report	24836-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	24836-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	24836-Scientific misconduct check.pdf
Scientific Editor Work List	24836-Scientific editor work list.pdf